Vitruvian Partners’s Xometry XMTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.5M Sell
181,169
-10,750
-6% -$768K 8.7% 3
2026
Q1
$7.84M Hold
191,919
7.01% 4
2025
Q4
$11.4M Sell
191,919
-43,741
-19% -$2.47M 8.2% 4
2025
Q3
$12.8M Sell
235,660
-37,400
-14% -$1.62M 8.9% 4
2025
Q2
$9.23M Sell
273,060
-61,725
-18% -$1.81M 5.62% 5
2025
Q1
$8.34M Buy
334,785
+68,500
+26% +$2.15M 7.96% 4
2024
Q4
$11.4M Sell
266,285
-93,200
-26% -$2.64M 9.78% 4
2024
Q3
$6.6M Hold
359,485
2.56% 5
2024
Q2
$4.16M Hold
359,485
1.22% 7
2024
Q1
$6.07M Buy
359,485
+193,263
+116% +$5.24M 1.93% 7
2023
Q4
$5.97M Buy
166,222
+42,368
+34% +$909K 1.52% 7
2023
Q3
$2.1M Buy
123,854
+60,516
+96% +$1.15M 0.6% 9
2023
Q2
$1.34M Buy
+63,338
New +$1.11M 0.27% 9

Other funds holding XMTR

Vitruvian Partners's XMTR Position: Q2 2026 in Review

Vitruvian Partners reduced its Xometry (XMTR) stake by 5.6% in Q2 2026, selling an estimated $768K and leaving 181,169 shares worth $17.5M. The position accounts for 8.7% of the portfolio, ranked #3.

Vitruvian Partners first reported a position in XMTR in Q2 2023 and has held it in 13 quarters since. 294 funds tracked by Wall St. Rank hold XMTR as of Q2 2026.

  • Vitruvian Partners held 181,169 shares of Xometry worth $17.5M as of Q2 2026.
  • Vitruvian Partners sold 10,750 Xometry shares in Q2 2026, an estimated $768K.
  • Xometry made up 8.7% of Vitruvian Partners's portfolio in Q2 2026, its #3 holding.
  • Vitruvian Partners first reported a position in Xometry in Q2 2023 and has held it in 13 quarters since.
  • 294 funds tracked by Wall St. Rank held Xometry as of Q2 2026.

Based on Vitruvian Partners's 13F filing for Q2 2026, filed 10 Aug 2026.